TMDX TransMedics Group, Inc.

NASDAQ
$85.29

TransMedics Group, Inc. (TMDX) is expected to report earnings on November 4, 2026, after the market close. The consensus earnings estimate is $0.27 per share, and the stock has had a Post-Earnings Announcement Drift (PEAD) of +17.9% since its last earnings release on August 4, 2026.

TransMedics Group Missed Consensus Estimates, Narrows Guidance
Tuesday, August 4, 2026 · 4:05 PM ET
Earnings Date
3rd Quarter, Sep 2026
Nov 4
Wednesday · 4:05 PM ET
Earnings Whisper
-
vs $0.27
Rev est $179.95M
Volatility
Enter your expectations below to reveal the current volatility.
Trend Analysis
Expectation
Earnings
Price action
Signals
Score
Sentiment
Grade
Life Cycle
Call Analysis
Earnings-AVWAP $86.32

Sign in or subscribe to unlock sentiment, short interest, and technical indicators.

About TransMedics Group, Inc.

TransMedics is the world's leader in portable extracorporeal warm perfusion and assessment of donor organs for transplantation.

Sector

Healthcare

Industry

Medical Appliances/Equipment

Held By 4 ETFs, by dollar flow

Charts powered in part by Lightweight Charts™ by TradingView.